Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sella Provan"'
Autor:
Gyda Ullensvang, Ester Kringeland, Eirik Ikdahl, Sella Provan, Inger Jorid Berg, Silvia Rollefstad, Hanne Dagfinrud, Eva Gerdts, Anne Grete Semb, Helga Midtbø
Publikováno v:
Blood Pressure, Vol 32, Iss 1 (2023)
Purpose Hypertension is a major cardiovascular (CV) risk factor in ankylosing spondylitis (AS) patients. Less is known about the prevalence of CV organ damage in relation to hypertension status in AS patients. Materials and Methods CV organ damage wa
Externí odkaz:
https://doaj.org/article/47d7c5e75b1b4e279f41d9cd994dbc35
Autor:
Daniela Di Giuseppe, Ulf Lindström, Kalle Aaltonen, Heikki Relas, Sella Provan, Bjorn Gudbjornsson, Merete Lund Hetland, Johan Askling, Markku Kauppi, Arni Jon Geirsson, Katerina Chatzidionysiou, Tanja Schjødt Jørgensen, Lene Dreyer, Brigitte Michelsen, Lennart Jacobsson, Bente Glintborg
Publikováno v:
Di Giuseppe, D, Lindström, U, Aaltonen, K, Relas, H, Provan, S, Gudbjornsson, B, Hetland, M L, Askling, J, Kauppi, M, Geirsson, A J, Chatzidionysiou, K, Jørgensen, T S, Dreyer, L, Michelsen, B, Jacobsson, L & Glintborg, B 2022, ' The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries ', Rheumatology, vol. 61, no. 9, keab946, pp. 3647–3656 . https://doi.org/10.1093/rheumatology/keab946
Objectives In axial spondyloarthritis (axSpA), switching between multiple biologic or targeted synthetic (b/ts-) DMARDs might indicate difficult-to-treat disease. We aimed to explore the occurrence of multiple switching in routine care axSpA patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9a2d4801f234b6c584b486d42bf721e
https://vbn.aau.dk/da/publications/c69a6080-c6c8-4fc7-8971-2cdc61d337ae
https://vbn.aau.dk/da/publications/c69a6080-c6c8-4fc7-8971-2cdc61d337ae